Skip to main content

Find Clinical Trials

Home
Conditions
Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM

Clinical trial condition

Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM

Explore clinical trials studying Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM trial results

Completed

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

NCT01760655

Conditions: Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM, +61 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details